Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANNA-B PK study of antiretroviral pharmacokinetics in breast milk
NL-OMON53659Phase 4Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of doravirine, raltegravir, bictegravir, emtricitabine and tenofovir alafenamide in human immunodeficiency virus infection (HIV) (3 arms), sponsored by Radboud University Medical Center. Primary endpoint: Milk-to-plasma ratio. Started Sep 2023; status: recruiting.
02
Drugs
doravirineraltegravirbictegraviremtricitabinetenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON53659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53659.